Cyclerion Therapeutics, Inc. Common Stock (CYCN) is a publicly traded Healthcare sector company. As of May 21, 2026, CYCN trades at $3.02 with a market cap of $13.08M and a P/E ratio of -2.27. CYCN moved +4.33% today. Year to date, CYCN is +123.19%; over the trailing twelve months it is -6.21%. Its 52-week range spans $1.03 to $9.47. Rallies surfaces CYCN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Cyclerion Therapeutics, Inc. Common Stock (CYCN) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. CYCN moved +4.33% today.
| Metric | Value |
|---|---|
| Price | $3.02 |
| Market Cap | $13.08M |
| P/E Ratio | -2.27 |
| EPS | $-1.36 |
| Dividend Yield | 0.00% |
| 52-Week High | $9.47 |
| 52-Week Low | $1.03 |
| Volume | 26 |
| Avg Volume | 0 |
| Revenue (TTM) | $1.99M |
| Net Income | $-5.28M |
| Gross Margin | 0.00% |
CYCN analyst coverage data. Average price target: $0.00.